
pmid: 36439169
pmc: PMC9682132
handle: 10261/286001 , 20.500.14352/73418 , 10366/154088 , 20.500.12530/96691
pmid: 36439169
pmc: PMC9682132
handle: 10261/286001 , 20.500.14352/73418 , 10366/154088 , 20.500.12530/96691
SARS-CoV-2 vaccines currently in use have contributed to controlling the COVID-19 pandemic. Notwithstanding, the high mutation rate, fundamentally in the spike glycoprotein (S), is causing the emergence of new variants. Solely utilizing this antigen is a drawback that may reduce the efficacy of these vaccines. Herein we present a DNA vaccine candidate that contains the genes encoding the S and the nucleocapsid (N) proteins implemented into the non-replicative mammalian expression plasmid vector, pPAL. This plasmid lacks antibiotic resistance genes and contains an alternative selectable marker for production. The S gene sequence was modified to avoid furin cleavage (Sfs). Potent humoral and cellular immune responses were observed in C57BL/6J mice vaccinated with pPAL-Sfs + pPAL-N following a prime/boost regimen by the intramuscular route applying in vivo electroporation. The immunogen fully protected K18-hACE2 mice against a lethal dose (105 PFU) of SARS-CoV-2. Viral replication was completely controlled in the lungs, brain, and heart of vaccinated mice. Therefore, pPAL-Sfs + pPAL-N is a promising DNA vaccine candidate for protection from COVID-19.
DNA vaccine, 2412 Inmunología, COVID-19 Vaccines, mouse model, ADN, Immunology, Inmunología, furina, N protein, Mouse model, 615.371, S protein, Tecnología farmaceútica, Mice, pPAL, 615.46, Vaccines, DNA, Animals, Humans, 3209 Farmacolog?a, 578.834, Pandemics, Furin, Mammals, Mice, Inbred BALB C, SARS-CoV-2, virus del SRAS, COVID-19, Viral Vaccines, DNA, 546, RC581-607, SARS Virus, Química inorgánica (Farmacia), Anti-Bacterial Agents, Mice, Inbred C57BL, 3209 Farmacología, Immunologic diseases. Allergy, 6310.03 Enfermedad, furin
DNA vaccine, 2412 Inmunología, COVID-19 Vaccines, mouse model, ADN, Immunology, Inmunología, furina, N protein, Mouse model, 615.371, S protein, Tecnología farmaceútica, Mice, pPAL, 615.46, Vaccines, DNA, Animals, Humans, 3209 Farmacolog?a, 578.834, Pandemics, Furin, Mammals, Mice, Inbred BALB C, SARS-CoV-2, virus del SRAS, COVID-19, Viral Vaccines, DNA, 546, RC581-607, SARS Virus, Química inorgánica (Farmacia), Anti-Bacterial Agents, Mice, Inbred C57BL, 3209 Farmacología, Immunologic diseases. Allergy, 6310.03 Enfermedad, furin
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 10 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
